Proposed Rule2023-23701
Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material; Extension of Comment Period
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 27, 2023
Effective
July 3, 2023
Issuing agencies
Nuclear Regulatory Commission
Abstract
On July 3, 2023, the U.S. Nuclear Regulatory Commission (NRC) solicited comments on the regulatory basis for the planned rulemaking on "Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material." The public comment period was originally scheduled to close on October 31, 2023. The NRC has decided to extend the public comment period to allow more time for members of the public to develop and submit their comments.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 207 (Friday, October 27, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 207 (Friday, October 27, 2023)]
[Proposed Rules]
[Pages 73766-73767]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-23701]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
10 CFR Part 35
[NRC-2018-0297]
RIN 3150-AK80
Rubidium-82 Generators, Emerging Technologies, and Other Medical
Use of Byproduct Material; Extension of Comment Period
AGENCY: Nuclear Regulatory Commission.
ACTION: Regulatory basis; extension of comment period.
-----------------------------------------------------------------------
SUMMARY: On July 3, 2023, the U.S. Nuclear Regulatory Commission (NRC)
solicited comments on the regulatory basis for the planned rulemaking
on ``Rubidium-82 Generators, Emerging Technologies, and Other Medical
Use of Byproduct Material.'' The public comment period was originally
scheduled to close on October 31, 2023. The NRC has decided to extend
the public comment period to allow more time for members of the public
to develop and submit their comments.
DATES: The due date of comments requested in the document published on
July 3, 2023 (88 FR 42654) is extended. Comments should be filed no
later than December 15, 2023. Comments received after this date will be
considered, if it is practical to do so, but the NRC is able to ensure
consideration only for comments received on or before this date.
ADDRESSES: You may submit comments by any of the following methods;
however, the NRC encourages electronic comment submission through the
Federal rulemaking website:
<bullet> Federal Rulemaking website: Go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and search for Docket ID NRC-2018-0297. Address
questions about NRC dockets to Dawn Forder; telephone: 301-415-3407;
email: <a href="/cdn-cgi/l/email-protection#511530263f7f173e23353423113f23327f363e27"><span class="__cf_email__" data-cfemail="c88ca9bfa6e68ea7baacadba88a6baabe6afa7be">[email protected]</span></a>. For technical questions contact the
individuals listed in the FOR FURTHER INFORMATION CONTACT section of
this document.
<bullet> Email comments to: <a href="/cdn-cgi/l/email-protection#8fddfae3eae2eee4e6e1e8a1cce0e2e2eae1fbfccfe1fdeca1e8e0f9"><span class="__cf_email__" data-cfemail="2674534a434b474d4f48410865494b4b434852556648544508414950">[email protected]</span></a>. If you do
not receive an automatic email reply confirming receipt, then contact
us at 301-415-1677.
<bullet> Fax comments to: Secretary, U.S. Nuclear Regulatory
Commission at 301-415-1101.
<bullet> Mail comments to: Secretary, U.S. Nuclear Regulatory
Commission, Washington, DC 20555-0001, ATTN: Rulemakings and
Adjudications Staff.
<bullet> Hand deliver comments to: 11555 Rockville Pike, Rockville,
Maryland 20852, between 7:30 a.m. and 4:15 p.m. eastern time, Federal
workdays; telephone: 301-415-1677.
For additional direction on obtaining information and submitting
comments, see ``Obtaining Information and Submitting Comments'' in the
SUPPLEMENTARY INFORMATION section of this document.
FOR FURTHER INFORMATION CONTACT: Andrew Carrera, Office of Nuclear
Material Safety and Safeguards, telephone: 301-415-1078, email:
<a href="/cdn-cgi/l/email-protection#c687a8a2b4a3b1e885a7b4b4a3b4a786a8b4a5e8a1a9b0"><span class="__cf_email__" data-cfemail="73321d170116045d30120101160112331d01105d141c05">[email protected]</span></a>; and Maryann Ayoade, Office of Nuclear Material
Safety and Safeguards, telephone: 301-415-0862, email:
<a href="/cdn-cgi/l/email-protection#a3eec2d1dac2cdcd8de2daccc2c7c6e3cdd1c08dc4ccd5"><span class="__cf_email__" data-cfemail="266b47545f47484808675f494742436648544508414950">[email protected]</span></a>. Both are staff of the U.S. Nuclear Regulatory
Commission, Washington, DC 20555-0001.
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC-2018-0297 when contacting the NRC
about the availability of information for this action. You may obtain
publicly available information related to this action by any of the
following methods:
<bullet> Federal Rulemaking Website: Go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and search for Docket ID NRC-2018-0297.
<bullet> NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly available documents online in the
ADAMS Public Documents collection at <a href="https://www.nrc.gov/reading-rm/adams.html">https://www.nrc.gov/reading-rm/adams.html</a>. To begin the search, select ``Begin Web-based ADAMS
Search.'' For problems with ADAMS, please contact the NRC's Public
Document Room (PDR) reference staff at 1-800-397-4209, at 301-415-4737,
or by email to <a href="/cdn-cgi/l/email-protection#3f6f7b6d116d5a4c504a4d5c5a7f514d5c11585049"><span class="__cf_email__" data-cfemail="257561770b7740564a50574640654b57460b424a53">[email protected]</span></a>. The ADAMS accession number for
each document referenced (if it is available in ADAMS) is provided the
first time that it is mentioned in this document.
<bullet> NRC's PDR: The PDR, where you may examine and order copies
of publicly available documents, is open by appointment. To make an
appointment to visit the PDR, please send an email to
<a href="/cdn-cgi/l/email-protection#237367710d7146504c56514046634d51400d444c55"><span class="__cf_email__" data-cfemail="c5958197eb97a0b6aab0b7a6a085abb7a6eba2aab3">[email protected]</span></a> or call 1-800-397-4209 or 301-415-4737, between 8
a.m. and 4 p.m. eastern time, Monday through Friday, except Federal
holidays.
B. Submitting Comments
The NRC encourages electronic comment submission through the
Federal Rulemaking website (https://
[[Page 73767]]
www.regulations.gov). Please include Docket ID NRC-2018-0297 in your
comment submission.
The NRC cautions you not to include identifying or contact
information that you do not want to be publicly disclosed in your
comment submission. The NRC will post all comment submissions at
<a href="https://www.regulations.gov">https://www.regulations.gov</a> as well as enter the comment submissions
into ADAMS. The NRC does not routinely edit comment submissions to
remove identifying or contact information.
If you are requesting or aggregating comments from other persons
for submission to the NRC, then you should inform those persons not to
include identifying or contact information that they do not want to be
publicly disclosed in their comment submission. Your request should
state that the NRC does not routinely edit comment submissions to
remove such information before making the comment submissions available
to the public or entering the comment into ADAMS.
II. Discussion
On July 3, 2023, the NRC solicited comments on the regulatory basis
for a planned rulemaking on ``Rubidium-82 Generators, Emerging
Technologies, and Other Medical Use of Byproduct Material.'' The public
comment period was originally scheduled to close on October 31, 2023.
By letter dated October 19, 2023 (ADAMS Accession No. ML23292A176), the
Mercurie Consulting, LLC; American Association of Physicist in
Medicine; American College of Radiology; American Society of Radiation
Oncology; and Society of Nuclear Medicine and Medical Imaging requested
that the NRC extend the comment period by 45 days. The NRC has decided
to grant this request and extend the public comment period on this
document until December 15, 2023, to allow more time for members of the
public to submit their comments.
The NRC may post materials related to this document, including
public comments, on the Federal rulemaking website at <a href="https://www.regulations.gov">https://www.regulations.gov</a> under Docket ID NRC-2018-0297. In addition, the
Federal rulemaking website allows members of the public to receive
alerts when changes or additions occur in a docket folder. To
subscribe: (1) navigate to the docket folder (NRC-2018-0297); (2) click
the ``Subscribe'' link; and (3) enter an email address and click on the
``Subscribe'' link.
Dated: October 23, 2023.
For the Nuclear Regulatory Commission.
Catherine E. Kanatas,
Acting Deputy Director, Division of Rulemaking, Environmental, and
Financial Support, Office of Nuclear Material Safety and Safeguards.
[FR Doc. 2023-23701 Filed 10-26-23; 8:45 am]
BILLING CODE 7590-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 27, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.